CTL works diligently with Cornell researchers and innovators by bringing their inventions from the lab to the marketplace. As Cornell’s technology commercialization office, we are exploring new ways to create business opportunities, launching new ventures, and helping to commercialize Cornell technologies. Learn more about CTL’s annual activities and metrics.
Commercializing
109
Licenses & Options
FY2020-2024:
477 Licenses & Options
$22 M
Revenue Generated
FY2020-2024:
$122M Revenue Generated
Venturing
10
New Startups Based on Cornell IP
$418.6 M
Funding Raised by Startups in FY24
- Neuralenz
- Kubbly
- BiaWear
- Anova Biomedical
- Astoria Biologica
- Carbon to Stone
- ExoPower
- Giant Biosystems
- Graphenode
- Sacyl Pharmaceuticals
FY2020-2024:
$2.3B Funding Raised by Startups
Protecting
169
US Non-Provisional Patent Applications
| Filed Location | 2020 | 2021 | 2022 | 2023 | 2024 |
| U.S. Provisional | 158 | 163 | 163 | 164 | 143 |
| U.S. Nonprovisional | 195 | 179 | 164 | 169 | 169 |
| International | 322 | 304 | 318 | 217 | 251 |
| Total | 675 | 646 | 645 | 550 | 544 |
107
US Issued Patents
| FY | 2020 | 2021 | 2022 | 2023 | 2024 |
| U.S. | 124 | 127 | 79 | 104 | 107 |
| International | 284 | 191 | 142 | 117 | 144 |
| Total | 408 | 318 | 221 | 221 | 251 |
Ideating
34
Educational Programs Offered
70
Office Hours
313
IP Disclosures
Recent News
In September, the U.S. Food and Drug Administration formally approved elamipretide as a treatment for Barth syndrome under an expedited process for rare diseases. The achievement is the realization of a two-decade-long…
Startup stories move differently from the lab to real-world impact. Some grow with a public launch, others by building a strong customer base for their innovative product or service. And…
REEgen, a company with technology licensed from Cornell, has won the $150,000 grand prize at the 2025 FuzeHub Commercialization Competition. The company competed against eleven other innovative New York State startups…
Wearable devices and hospital monitors may dominate conversations about remote health care, but a new Cornell-affiliated startup is betting its future on something almost invisible: radio waves. SensVita, a company…
